Physician profile
Steven Baum
NPI 1205339090
$208.82
in general payments reported to CMS, 2019-2025
9 companies · $24.76 in 2025
The $24.76 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.73 · 2023: $42.11 · 2024: $107 · 2025: $24.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $48.92 | 2024-2025 | Watchman, Accolade Sr |
| Dynavax Technologies Corporation | $34.73 | 2021 | |
| Exact Sciences Corporation | $25.03 | 2023 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $20.80 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $18.12 | 2024 | Breztri |
| Glaxosmithkline, LLC. | $17.08 | 2023 | Arexvy, Shingrix |
| Amgen INC. | $15.37 | 2024 | Repatha, Otezla |
| Lilly USA, LLC | $15.10 | 2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $13.67 | 2024 | Vaxneuvance, Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.